Back

Six-month echocardiographic follow-up of left bundle branch optimized cardiac resynchronization therapy (LOT-CRT) versus traditional CRT

30 March 2025 (09:30 - 10:15)
Organised by: Logo
Congress Presentation Part of: Cardiac resynchronisation therapy Cardiac Resynchronisation Therapy (CRT) EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Pugazhendhi Vijayaraman

Geisinger Health System, Wilkes Barre (United States of America)

4 More presentations in this session

Presentation thumbnail
In CRT candidates, left septal myocardial capture in close proximity to the left bundle branch provides the same LV work effectivity and left ventricular synchrony as direct left bundle branch pacing
Mr L. Poviser (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
AV block occurrence in normal AV conduction CRT fusion pacing: single center experience
Doctor A. Faur (Timisoara, RO)
Abstract Slides Video
Presentation thumbnail
Left ventricle lead placement in areas with a higher CART score, indicating late mechanical activation, is associated with greater response in cardiac resynchronisation therapy patients
Mr W. Gerrits (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
SGLT2 inhibitors promote electrical remodeling in heart failure patients undergoing cardiac resynchronization therapy: a clinical and metabolomic analysis
Doctor G. Arabia (Brescia, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac resynchronisation therapy

The Event

Event poster

EHRA 2025

30 March 2025 09:30 CET
You may be interested in
thumbnail
Congress Presentation
Left bundle branch pacing-optimized cardiac resynchronization vs biventricular therapy: electrical/echocardiographic response; according to QRS morphology/duration, indication and cardiomyopathy
thumbnail
Congress Presentation
Cardiac resynchronization therapy guided by interventricular delay: how to choose between biventricular pacing or conduction system pacing.
thumbnail
Congress Presentation
LECART: LBBAP vs BiVP trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources